Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis
- PMID: 38466368
- PMCID: PMC11043315
- DOI: 10.1007/s44197-024-00190-z
Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis
Abstract
Leishmaniasis is a disease of poverty that imposes a devastating medical, social, and economic burden on over 1 billion people nationwide. To date, no in-depth study to analyze the major global challenges and needs assessment has been carried out. This investigation aimed to explore a comprehensive narrative review of leishmaniasis's main challenges and initially highlight obstacles that might impede the implementation of control measures. Also, we propose a specific list of priorities for needs assessment. The presence of socioeconomic factors, multiple clinical and epidemiological forms, various Leishmania species, the complexity of the life cycle, the absence of effective drugs and vaccines, and the lack of efficient vector and reservoir control make this organism unique and sophisticated in playing a tangled role to react tricky with its surrounding environments, despite extensive efforts and implementation of all-inclusive former control measures. These facts indicate that the previous strategic plans, financial support, and basic infrastructures connected to leishmaniasis surveillance are still insufficient. Strengthening the leishmaniasis framework in a context of accelerated programmatic action and intensification of cross-cutting activities along with other neglected tropical diseases (NTDs) is confidently expected to result in greater effectiveness, cost-benefit, and fruitful management. Sensitive diagnostics, effective therapeutics, and efficacious vaccines are vital to accelerating advancement toward elimination, and reducing morbidity/mortality and program costs. Collective actions devoted by all sectors and policy-makers can hopefully overcome technical and operational barriers to guarantee that effective and coordinated implementation plans are sustained to meet the road map for NTDs 2021- 2030 goals.
Keywords: Control strategies; Development goals; Leishmaniasis challenges; Needs assessment.
© 2024. The Author(s).
Conflict of interest statement
The authors have no competing interests to declare that are relevant to the content of this article.
Figures



Similar articles
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
-
Innovation in neglected tropical disease drug discovery and development.Infect Dis Poverty. 2018 Jun 18;7(1):67. doi: 10.1186/s40249-018-0444-1. Infect Dis Poverty. 2018. PMID: 29950174 Free PMC article. Review.
-
Review of the neglected tropical diseases programme implementation during 2012-2019 in the WHO-Eastern Mediterranean Region.PLoS Negl Trop Dis. 2022 Sep 29;16(9):e0010665. doi: 10.1371/journal.pntd.0010665. eCollection 2022 Sep. PLoS Negl Trop Dis. 2022. PMID: 36173943 Free PMC article. Review.
-
Neglected tropical diseases: an effective global response to local poverty-related disease priorities.Infect Dis Poverty. 2020 Jan 28;9(1):10. doi: 10.1186/s40249-020-0630-9. Infect Dis Poverty. 2020. PMID: 31987053 Free PMC article. Review.
Cited by
-
Prevalence of human visceral leishmaniasis and its risk factors in Eastern Africa: a systematic review and meta-analysis.Front Public Health. 2024 Nov 21;12:1488741. doi: 10.3389/fpubh.2024.1488741. eCollection 2024. Front Public Health. 2024. PMID: 39659723 Free PMC article.
-
Evaluation of the Anti-Leishmanial Activity of the Hydroalcoholic Extract of Green Algae (Spirogyra): Investigation of Weight Indicators (Lesion Size and Organ Weights) in BALB/c Mice.Acta Parasitol. 2025 Feb 7;70(1):51. doi: 10.1007/s11686-025-00994-4. Acta Parasitol. 2025. PMID: 39918617
-
Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors.Pharmaceuticals (Basel). 2024 Dec 24;18(1):6. doi: 10.3390/ph18010006. Pharmaceuticals (Basel). 2024. PMID: 39861069 Free PMC article.
-
Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone.Pharmaceutics. 2025 Mar 21;17(4):399. doi: 10.3390/pharmaceutics17040399. Pharmaceutics. 2025. PMID: 40284397 Free PMC article.
-
An inclusive assessment of apoptosis mechanisms in Leishmania species: A narrative literature review.Curr Res Parasitol Vector Borne Dis. 2025 Apr 17;7:100260. doi: 10.1016/j.crpvbd.2025.100260. eCollection 2025. Curr Res Parasitol Vector Borne Dis. 2025. PMID: 40589914 Free PMC article. Review.
References
-
- WHO. WHO to implement online epidemiological surveillance for leishmaniasis. Available [Http://WwwWhoInt/Neglected_diseases/News/WHO_implement_epidemiological_surveillance_leishmaniasis/En] 2016.
-
- WHO. Leishmaniasis, Status of endemicity of cutaneous leishmaniasis: 2019. 2020–06–15)[2020–09–08] Https//Apps Who Int/Neglected_diseases/Ntddata/Leishmaniasis/Leishmaniasis Html 2019.
-
- Bamorovat M, Sharifi I, Afshari SAK, Karamoozian A, Tahmouresi A, Heshmatkhah A, et al. Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: a case-control field assessment in Iran. Int J Parasitol Drugs Drug Resist. 2023;21:21–27. doi: 10.1016/j.ijpddr.2022.11.006. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical